Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
RCM Technologies
RCMT
$248M
| $2.12M | ﹤0.01% |
705,462
+1,900
| +0.3% | +$5.46K |
|
2302
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $2.12M | ﹤0.01% |
+21,000
| New | +$2.11M |
|
|
JT
2303
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $2.1M | ﹤0.01% |
176,509
+20,585
| +13% | +$324K |
|
2304
Astronics
ATRO
$4.61B
| $2.1M | ﹤0.01% |
+90,000
| New | +$2.21M |
|
|
INDT
2305
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $2.09M | ﹤0.01% |
52,900
+1,800
| +4% | +$70K |
|
2306
Investar Holding Corp
ISTR
$426M
| $2.09M | ﹤0.01% |
86,975
+18,615
| +27% | +$458K |
|
2307
Cartesian Therapeutics
RNAC
$267M
| $2.08M | ﹤0.01% |
29,142
+7,996
| +38% | +$386K |
|
2308
Harmonic Inc
HLIT
$1.51B
| $2.08M | ﹤0.01% |
266,626
-482,347
| -64% | -$3.6M |
|
2309
PCB Bancorp
PCB
$399M
| $2.08M | ﹤0.01% |
120,332
+34,662
| +40% | +$583K |
|
2310
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $2.07M | ﹤0.01% |
23,700
+19,574
| +474% | +$1.71M |
|
2311
Lesaka Technologies
LSAK
$407M
| $2.07M | ﹤0.01% |
555,722
-82,978
| -13% | -$275K |
|
|
VSA
2312
VisionSys AI
VSA
$9.27M
| $2.06M | ﹤0.01% |
420
+42
| +11% | +$100K |
|
2313
Ascent Industries
ACNT
$136M
| $2.05M | ﹤0.01% |
158,600
+1,900
| +1% | +$26.4K |
|
|
MSBF
2314
DELISTED
MSB Financial Corp.
MSBF
| $2.05M | ﹤0.01% |
113,703
+3,903
| +4% | +$62.4K |
|
|
RADA
2315
DELISTED
Rada Electronic Industries Ltd
RADA
| $2.05M | ﹤0.01% |
394,124
-78,800
| -17% | -$412K |
|
|
CVET
2316
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.04M | ﹤0.01% |
+154,600
| New | +$1.87M |
|
2317
Ark Restaurants
ARKR
$20.2M
| $2.04M | ﹤0.01% |
90,600
+2,395
| +3% | +$49.6K |
|
2318
NWPX Infrastructure Inc
NWPX
$1.12B
| $2.04M | ﹤0.01% |
61,100
+4,000
| +7% | +$126K |
|
2319
Lantronix
LTRX
$289M
| $2.03M | ﹤0.01% |
572,564
+16,300
| +3% | +$55K |
|
2320
Rogers Corp
ROG
$2.55B
| $2.03M | ﹤0.01% |
16,300
-43,500
| -73% | -$5.88M |
|
2321
Pearson
PSO
$9.72B
| $2.03M | ﹤0.01% |
241,100
-137,300
| -36% | -$1.18M |
|
2322
Griffon
GFF
$4.72B
| $2.03M | ﹤0.01% |
99,800
-2,700
| -3% | -$56.7K |
|
|
HT
2323
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $2.03M | ﹤0.01% |
139,400
+16,839
| +14% | +$239K |
|
2324
Garrett Motion
GTX
$5.41B
| $2.03M | ﹤0.01% |
202,829
-28,520
| -12% | -$291K |
|
|
QUMU
2325
DELISTED
Qumu Corp.
QUMU
| $2.02M | ﹤0.01% |
772,856
+6,702
| +0.9% | +$18.4K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.